Nureca Limited has announced the postponement of its board meeting, which was originally scheduled for November 10, 2025. The meeting aimed to discuss a proposal for a buyback of equity shares; however, it has been delayed indefinitely due to the non-availability of a majority of Independent Directors. This decision comes as a significant development for the company, which is currently navigating the intricacies of board governance and shareholder engagement.

In addition to the postponement, Nureca Limited has confirmed that the trading window will open on November 10, 2025 for all Directors and Designated Officers, in accordance with its Code of Conduct for the Prevention of Insider Trading. This update reflects the company's commitment to maintaining transparency and compliance with regulatory standards. Stakeholders are advised to adjust their expectations accordingly as the company works towards rescheduling the important meeting.